Safety and Efficacy Results from a Phase II Trial of De-Escalated Ptcy and Ruxolitinib for GVHD Prophylaxis in Older Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

View at publisher
Authors: Sameem M. Abedin, Lyndsey Runaas, Nirav Niranjan Shah, Marcelo C. Pasquini, Walter Longo, Fateeha Furqan, William R. Drobyski, Xue‐Zhong Yu, Mehdi Hamadani
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S78–S79
Publication date
1 February 2026
Language
EN